The Effects of Late Toxicities on Outcomes in Long-Term Survivors of Ex-Vivo CD34+− Selected Allogeneic Hematopoietic Cell Transplantation

The late adverse events in long-term survivors after myeloablative conditioned allogeneic hematopoietic cell transplantation with ex-vivo CD34+ selection are not well characterized. Using the National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE) version 4.0, we asses...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Biol Blood Marrow Transplant
Main Authors: Scordo, Michael, Shah, Gunjan L., Kosuri, Satyajit, Herrera, Diego Adrianzen, Cho, Christina, Devlin, Sean M., Maloy, Molly A., Nieves, Jimmy, Borrill, Taylor, Avecilla, Scott T., Meagher, Richard C., Carlow, Dean C., O’Reilly, Richard J., Papadopoulos, Esperanza B., Jakubowski, Ann A., Koehne, Guenther, Gyurkocza, Boglarka, Castro-Malaspina, Hugo, Tamari, Roni, Perales, Miguel-Angel, Giralt, Sergio A., Shaffer, Brian C.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6713288/
https://ncbi.nlm.nih.gov/pubmed/28870777
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2017.08.033
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados